Vedolizumab-4030: Understand the Outcomes of Inflammatory Bowel Disease (IBD) Patients Treated with Biologics in Taiwan – A Decentralized Vedolizumab and Biologic Agents Core Assessments in IBD Collaboration

ENCePP Code of conduct

No

Data sources

• Data source(s), other:
  Chang Gung Research Database (CGRD) Taiwan, China Medical University Hospital (CMUH)-Clinical Research Database Taiwan, National Taiwan University Hospital-integrated Medical database (NTUH-iMD) Taiwan, Taichung Veterans General Hospital (TVGH)-Research Database Taiwan
• Data sources (types):
  Electronic healthcare records (EHR)

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No